29 results on '"Archambault, Robert"'
Search Results
2. Testosterone recovery after androgen deprivation therapy in localised prostate cancer: Long-term data from two randomised trials
3. Hypofractionated Dose Escalation Radiotherapy for High-Risk Prostate Cancer: the survival analysis of the Prostate Cancer Study-5 (PCS-5), a GROUQ-led phase III trial
4. Impact of testosterone recovery after androgen deprivation therapy on overall survival in patients with high-risk prostate cancer: Long-term data from a phase III trial.
5. Androgen deprivation therapy and radiotherapy in intermediate-risk prostate cancer: A randomised phase III trial
6. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial
7. Weight variation during androgen deprivation therapy in patients with localized prostate cancer: Data from two prospective randomized trials.
8. Testosterone recovery in patients with prostate cancer treated with radiotherapy and different ADT duration: Long-term data from two randomized trials.
9. 109: Prostate Cancer-Specific Death Rates in Localized Prostate Cancer: Data from Two Randomized Trials
10. 425: Comparison of death rate from cardiovascular disease: prostate cancer patients vs general population
11. Optimizing Treatment in Intermediate-Risk Prostate Cancer: Secondary Analysis of a Randomized Phase 3 Trial
12. The Clinical Significance of Bone Mineral Density Changes Following Long-Term Androgen Deprivation Therapy in Localized Prostate Cancer Patients
13. 115 Optimal Hypofractionated Rectal Dose-Volume Constraint from the Prostate Cancer Patients of the PCS V Trial
14. 24 Subsequent Androgen Deprivation Therapy After Initial Treatment in Intermediate Risk Prostate Cancer: Prospective Data from a Phase III Trial
15. 125 Rectal Wall Versus Whole Rectum Dose: Which Volume Better Predicts Gastrointestinal Toxicity from Prostate External Beam Radiotherapy?
16. 199 The Clinical Significance of Bone Mineral Density Changes Following Long Term Androgen Deprivation Therapy in Prostate Cancer Patients Enrolled in the PCS V Trial
17. Hypofractionated, dose escalation radiotherapy for high-risk prostate cancer: The primary endpoint of a group led phase III trial. (PCS5).
18. Duration of androgen deprivation therapy in high risk prostate cancer: Final results of a randomized phase III trial.
19. Is there a relationship between testosterone levels at the end of short-term androgen deprivation therapy and outcomes in intermediate risk prostate cancer? Prospective data from a phase III trial.
20. Causes of death in intermediate- and high-risk prostate cancer treated with radiotherapy with or without androgen deprivation therapy: Analysis from two phase III trials.
21. A phase III trial of short-term androgen deprivation therapy in intermediate-risk prostate cancer treated with radiotherapy.
22. Place of short-term androgen deprivation therapy in intermediate-risk prostate cancer treated with radiotherapy: A phase III trial.
23. Long-term quality of life in high-risk prostate cancer: Results of a phase III randomized trial.
24. Duration of androgen deprivation therapy in high-risk prostate cancer: A randomized trial.
25. High-risk prostate cancer treated with pelvic radiotherapy and 36 versus 18 months of androgen blockade: Results of a phase III randomized study.
26. 724 TESTOSTERONE RECOVERY IN PATIENTS WITH HIGH RISK PROSTATE CANCER TREATED WITH 36 VS 18 MONTHS OF ANDROGEN BLOCKADE AND PELVIC IRRADIATION
27. Hypofractionated, Dose Escalation Radiation Therapy for High-Risk Prostate Cancer: The Safety Analysis of the Prostate Cancer Study-5, a Groupe de Radio-Oncologie Génito-Urinaire de Quebec Led Phase 3 Trial.
28. 54 Scattered Radiation to the Testis and Testosterone Secretion in Prostate Cancer Treated with Radiotherapy Alone.
29. 43 Does Testosterone Recovery After Androgen Deprivation Therapy Impact on Overall Survival in Patients Cured from Prostate Cancer? Long-Term Prospective Data.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.